{{ currentBoardShortName }}
  • Markets
  • Indices
  • Currencies
  • Energy
  • Metals
Markets
As of: {{timeStamp.date}}
{{timeStamp.time}}

Markets

{{ currentBoardShortName }}
  • Markets
  • Indices
  • Currencies
  • Energy
  • Metals
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}
{{data.symbol | reutersRICLabelFormat:group.RICS}}
 
{{data.netChng | number: 4 }}
{{data.netChng | number: 2 }}
{{data | displayCurrencySymbol}} {{data.price | number: 4 }}
{{data.price | number: 2 }}

Latest Videos

{{ currentStream.Name }}

Related Video

Continuous Play:
ON OFF

The information you requested is not available at this time, please check back again soon.

More Video

Feb 27, 2018

Shoppers Drug Mart signs supply deal with Aurora Cannabis

Shoppers Drug Mart

Security Not Found

The stock symbol {{StockChart.Ric}} does not exist

See Full Stock Page »

TORONTO -- Licensed producer Aurora Cannabis has signed a deal to supply medical marijuana to Shoppers Drug Mart.

The agreement is subject to Health Canada's approval of the pharmacy chain's application to dispense medical cannabis.

Aurora's products are expected to be sold online, as current Canadian regulations prohibit the sale of medical marijuana in pharmacy locations.

Shoppers Drug Mart's deal with Aurora comes after it recently signed similar deals with licensed medical marijuana producers Aphria, MedReleaf and Tilray.

The pharmacy chain's parent company Loblaw Companies Ltd. applied in October 2016 for a license to dispense medical marijuana.

Other pharmacies have also lined up similar supply agreements, such as deals between Maricann Group. and Lovell Drugs and CanniMed Therapeutics and PharmaChoice.